Global derma-cosmetic brand Mediheal has solidified its position as a leader in K-beauty, driven by science-backed, results-oriented skincare that continues to resonate with consumers worldwide. The brand recently achieved record-setting sales at Olive Young, South Korea’s leading beauty retailer.
Mediheal was named the No. 1 brand in total sales at Olive Young for a second consecutive year in 2024 and 2025, outperforming more than 3,000 competing brands. This milestone reportedly makes Mediheal the first brand since Olive Young’s founding in 1999 to secure the top spot twice.
The brand also received four major accolades at the Olive Young Awards, including No. 1 in the Toner Pad category; Global Trend Best Performer for the Madecassoside Blemish Pad; Global Trend Rising for the Madecassoside Blemish Repair serum; and the Mask category award for the Madecassoside Essential Sheet Mask.
Among these standout products, the Madecassoside Blemish Pad retained its No. 1 ranking for the second year running, while the Madecassoside Blemish Repair serum recorded an impressive 820% sales increase within one year of launch, highlighting madecassoside as a flagship ingredient driving global demand.
“Success at Olive Young is especially meaningful because it is where consumers discover K-beauty trends first,” said Johanna Kim, CEO and Creative Director of Mediheal. “The performance of our madecassoside line validates our product strategy as we look ahead to 2026 and reinforces our focus on scaling proven innovation from Korea to the US and other global markets.”
Mediheal’s achievements underscore the continued global expansion of K-beauty, as consumers increasingly seek skincare products that combine scientific efficacy with innovative formulations.
